TET1 re-expression induces Homeobox A9 (HOX9A) expression via demethylation of its promoter, decreasing cell invasion, tumor growth, and intravasation in MDA-MD-231 and MDA-MB-436 BC cells [65]. Here, TET1 is linked to breast cancer.